Monod Bio develops computational protein design tools utilizing artificial intelligence to advance life sciences and clinical diagnostics. The company offers specialized products like NovoBody, LuxSit™ Pro, and NovoLISA for protein engineering applications. Their platform enables the creation of novel proteins with desired functionalities for various biological uses.
Funding
$25M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
MCFounders
Product
Problem
Traditional methods for detecting proteins, toxins, antibodies, and other molecules often involve multiple steps, are time-consuming, and may lack the sensitivity required for early or accurate diagnosis. Existing diagnostic tools can be cumbersome, expensive, and require specialized equipment and trained personnel, limiting their accessibility and hindering rapid point-of-care applications.
Solution
Monod Bio is developing a biosensor platform that streamlines molecular detection by integrating binding, transduction, and amplification into a single-step process. This technology leverages computationally designed proteins to create highly specific and sensitive biosensors for a wide range of target molecules. By combining advanced protein engineering with innovative sensor technology, Monod Bio aims to provide rapid, accurate, and accessible diagnostic solutions for various applications. The platform's modular design allows for customization and adaptation to detect diverse analytes, enabling applications in healthcare, biotechnology, and environmental monitoring.
Target Audience
The primary target audience includes researchers in biotechnology and pharmaceutical companies, clinical diagnostic laboratories, and healthcare providers seeking rapid and accurate detection of proteins, toxins, antibodies, and other molecules.
Features
- Single-step detection process integrating binding, transduction, and amplification
- Computationally designed proteins for high specificity and sensitivity
- Customizable platform adaptable to detect diverse target molecules
- Potential for rapid, point-of-care diagnostics
- Streamlined workflow reducing time and complexity compared to traditional methods